Provided by Tiger Trade Technology Pte. Ltd.

Carpenter Technology

418.80
+3.480.84%
Volume:152.94K
Turnover:64.12M
Market Cap:20.76B
PE:39.81
High:423.33
Open:421.92
Low:414.43
Close:415.32
52wk High:625.99
52wk Low:228.00
Shares:49.56M
Float Shares:48.15M
Volume Ratio:0.91
T/O Rate:0.32%
Dividend:0.80
Dividend Rate:0.19%
EPS(TTM):10.52
EPS(LYR):10.52
ROE:25.75%
ROA:11.87%
PB:9.32
PE(LYR):39.81

Loading ...

Carpenter Tech Is Maintained at Overweight by Keybanc

Dow Jones
·
Apr 09

U.S. RESEARCH ROUNDUP-3M, CME Group, TransDigm Group

Reuters
·
Apr 08

Carpenter Technology Corp : TD Cowen Raises Target Price to $430 From $380

THOMSON REUTERS
·
Apr 08

Analysts Offer Insights on Industrial Goods Companies: UniFirst (UNF), GrafTech International (EAF) and Carpenter Technology (CRS)

TIPRANKS
·
Apr 06

Is It Too Late To Consider Carpenter Technology (CRS) After Its 136% One Year Surge

Simply Wall St.
·
Apr 03

Carpenter Technology to host conference call, webcast on fiscal Q3 results

Reuters
·
Apr 02

Carpenter Tech Initiated at Equal-Weight by Wells Fargo

Dow Jones
·
Apr 01

Wells Fargo Initiates Carpenter Technology at Equalweight With $400 Price Target

MT Newswires Live
·
Apr 01

U.S. RESEARCH ROUNDUP-Asana, PPG Industries, Verisign

Reuters
·
Apr 01

Over 70 Million Taxpayers Apply for Refunds, 5 Million Voluntarily Report Additional Tax Liabilities

Deep News
·
Apr 01

Tax Administration Reports Over 70 Million Taxpayers Applied for Income Tax Refunds

Deep News
·
Apr 01

Carpenter Technology (CRS) Receives a Hold from Wells Fargo

TIPRANKS
·
Apr 01

Autolus Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates

GlobeNewswire
·
Mar 27

Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire
·
Mar 27

Press Release: SeaStar Medical Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates

Dow Jones
·
Mar 26

Assessing Carpenter Technology (CRS) Valuation After Strong Multi‑Year Shareholder Returns

Simply Wall St.
·
Mar 24

Cabaletta Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

GlobeNewswire
·
Mar 23

Nyse Order Imbalance 162570.0 Shares on Sell Side

THOMSON REUTERS
·
Mar 21

Press Release: Antengene Announces 2025 Full-Year Results: First TCE Out-licensing Validates Platform Value and Marks Inflection Point Towards 2026 Profitability

Dow Jones
·
Mar 20